Professional Documents
Culture Documents
GUS1 Nephrolithiasis
GUS1 Nephrolithiasis
Why ???
The incidence of nephrolithiasis is increasing
especially in female
Up 50% risk of recurrence within the subsequent 10
years after first-time stone formers
A metabolic evaluation may not be economically
sound if it is applied to all patients with stone
disease …… But…..
A simplified metabolic evaluation has been
established
…….. So What The Indications??
Indications for a Metabolic Stone Evaluation
Recurrent stone formers
Strong family history of stones
Intestinal disease (particularly chronic diarrhea)
Pathologic skeletal fractures
Osteoporosis
History of urinary tract infection with calculi
Personal history of gout
Infirm health (unable to tolerate repeated stone episodes)
Solitary kidney
Anatomic abnormalities
Renal insufficiency
Stones composed of cystine, uric acid, or struvite
Basic Metabolic Evaluation
HISTORY : Hyperparathyroidism or hypercalcaemia, Hyperuricemia, Renal
tubular acidosis
X-RAY
STONE ANALYSIS : Ca, MAP, Uric Acid, Cystein, Carbonate etc.
BLOOD:
• SERUM CREATININE
• CALCIUM
• URIC ACID
URINE:
• Urinary sediment/dipstick test for:
Red cells
White cells
Bacteriuria (nitrite)
Urine culture in case of a possible bacteriuria
pH
CLINICAL PRESENTATION
PAIN
-
PAIN
KUB
- 5 typical location of stone impaction :
calyx
ureteropelvic junction (UPJ)
pelvic brim (iliacs)
posterior pelvis (broad ligament, females)
ureterovesical junction (UPJ)
KUB
Intravenous pyelogram (IVP)
- nowadays, rarely used in the acute setting
Ultrasound
- pregnancy & pediatrics : avoids radiation
- poor visualization of small renal & ureteral
stones
Non-contrast computed tomography
- 97% sensitive & 97% specific for stone
- 4 signs of obstruction :
hydroureter
perinephric stranding
hydronephrosis
nephromegaly
Imaging modalities
Preference Examination LE
number
1. Non-contrast CT 1
Pharmacological agent LE
1. Diclofenac sodium 1b
2. Indomethacin 1b
Ibuprofen
3. Hydromorphine 4
hydrochloride (+
atropine)
Methamizol
Pentazocine
Tramadol
Recommended indication for watchful waiting
- no evidence of infection
- pain well-controlled with oral medication
- stone < 5 mm
- no obstruction
Spontaneous stone passage rates based on
location :
- proximal : 20%
- distal : 70%
Spontaneous passage rates within 1 year :
< 4 mm 90%
4 – 6 mm 60%
> 6 mm 20%
Obstruksi ureter akut
prostaglandin
diuresis
Nyeri meningkat
Obstruksi ureter akut
Kerusakan ginjal :
terjadi oleh karena iskhemia infark /
nekrosis pada duktus koligentes dan
tubulus proksimalis
MEDICAL OPTIONS DURING EXPECTANT
MANAGEMENT
Pain control
AB prophylaxis
Alpha blockers
Ca channel blockers
steroids
INDICATIONS FOR ACTIVE
STONE REMOVAL
The stone diameter is > 7 mm (because of a low
rate of spontaneous passage)
Pain relief cannot be achieved
Stone obstruction associated with infection
Pyonephrosis or urosepsis
In single kidneys with obstruction
Bilateral obstruction
SURGERY
ESWL
Ureteroscopy
Percutaneous nephrolithotomy (PNL)
Laparascopy
Open surgery
SURGERY
ESWL
- imaging : fluoroscopy
- anesthesia : sedation or general
- potential long-term renal effect :
renal injury/scar, hypertension
- complications :
hematoma (<1%) UTI/sepsis
obstruction injury to organ
- contraindications :
pregnancy calcified aneurysm
morbid obesity bleeding diathesis
ESWL : Extra Corporeal Shock
Wave Lithotripsy
Sebelum ESWL
Foto setelah ESWL
Foto setelah ESWL
STONE FREE RATES
proximal distal
ureter ureter
<1.0 cm
ESWL 84% 85%
Ureteroscopy 56% 89%
PCNL 76% -
≥1.0 cm
ESWL 72% 74%
Ureteroscopy 44% 73%
PCNL 74% -
STONE FRAGMENTATION TECHNOLOGIES
Electrohydraulic lithotripsy
Holmium : YAG laser
Ballistic lithotripsy (pneumatic)
Ultrasonic lithotripsy
THANK YOU